US Stock MarketDetailed Quotes
VOR Vor Biopharma
- 1.270
- +0.432+51.55%
Close Dec 27 16:00 ET
- 1.270
- +0.000+0.01%
Post 19:59 ET
87.22MMarket Cap-0.77P/E (TTM)
1.270High0.920Low6.75MVolume0.990Open0.838Pre Close7.47MTurnover17.44%Turnover RatioLossP/E (Static)68.67MShares3.14052wk High1.20P/B49.16MFloat Cap0.63052wk Low--Dividend TTM38.71MShs Float63.620Historical High--Div YieldTTM41.77%Amplitude0.630Historical Low1.106Avg Price1Lot Size
About Vor Biopharma Company
Vor Biopharma, Inc. engages in developing cell therapies for treating cancer. It is a clinical-stage cell therapy company that combines a novel patient engineering approach with therapies to provide a single company solution for patients suffering from hematological malignancies. The company was founded by Aleks Radovic-Moreno and Siddhartha Mukherjee on December 30, 2015 and is headquartered in Cambridge, MA.
Company Profile
SymbolVOR
Company NameVor Biopharma
Listing DateFeb 5, 2021
Issue Price18.00
Founded2015
CEOMr. Robert Ang, M.B.A.,M.B.B.S.
MarketNASDAQ
Employees168
Fiscal Year Ends12-31
Address100 Cambridgepark Drive,Suite 101
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02140
Phone1-617-655-6580
Websitehttp://www.vorbio.com
Company Executives
- Name
- Position
- Salary
- Robert Ang, M.B.A.,M.B.B.S.
- Director, President, Interim Principal Financial Officer and Chief Executive Officer
- 2.69M
- Dr. Tirtha Chakraborty, PhD
- Chief Scientific Officer
- 1.31M
- Dr. Eyal C. Attar, M.D.
- Chief Medical Officer
- --
- Amy Quinlan
- Vice President, Finance and Interim Principal Accounting Officer
- --
- Matthew R. Patterson
- Chairman of the Board
- 185.60K
- Dr. Joshua Resnick, M.B.A.,M.D.
- Independent Director
- 157.50K
- Daniella Beckman
- Independent Director
- 164.10K
- Dr. Fouad Namouni, M.D.
- Independent Director
- --
- Dr. Sven Ante Lundberg, M.D.
- Independent Director
- 152.10K
- David Charles Lubner, C.P.A.,M.S.
- Independent Director
- 151.60K
Heat List
US
Overall
Symbol
Price
% Chg
No Data
